Gallstone formation and subsequent cholecystectomy after oncological gastric and esophageal resection.

Cancer Cholecystectomy Cholecystolithiasis Prophylactic

Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
10 Feb 2024
Historique:
received: 25 07 2023
accepted: 22 01 2024
medline: 10 2 2024
pubmed: 10 2 2024
entrez: 10 2 2024
Statut: epublish

Résumé

Gallstone formation is increased after gastric (GR) or esophageal resection (ER); however, the exact pathophysiology is not fully understood yet. Symptomatic cholecystolithiasis and the need for subsequent cholecystectomy after upper gastrointestinal resection can alter the outcome in oncological patients. There is an ongoing discussion if these patients benefit from a simultaneous prophylactic cholecystectomy. This study aims to analyze the risk of gallstone formation after GR or ER and the perioperative course of a subsequent cholecystectomy. In this study, all patients were included, who underwent an oncological gastric or esophageal resection at the Medical University of Innsbruck, Department of Visceral, Transplant and Thoracic Surgery in the years 2003-2021. A simultaneous cholecystectomy was performed in 29.8% with GR and in 2.1% with ER (p < 0.001). There was no significant difference in complications or length-of-stay between patients with simultaneous vs. no simultaneous cholecystectomy. Newly developed gallstones tended to be more common after GR (16% vs. 10% ER), after reconstruction without preservation of the duodenal passage (17% vs. 11% with) and after GR with lymph node dissection (19% vs. 5% without). After ER, subsequent cholecystectomy was significant less frequently (11.4% vs. 2.9% OR) (p = 0.005). The subsequent cholecystectomy was performed openly in 57.1% with major complications classified as Clavien-Dindo ≥ 3a in 14.3%. Based on the findings of our study, we do not recommend simultaneous cholecystectomy routinely in oncological gastric or esophageal resections. An individualized approach depending on risk factors like extensive lymphadenectomy or duodenal passage can be discussed.

Identifiants

pubmed: 38337043
doi: 10.1007/s00423-024-03242-x
pii: 10.1007/s00423-024-03242-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

57

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Gillen S, Michalski CW, Schuster T, Feith M, Friess H, Kleeff J (2010) Simultaneous/Incidental cholecystectomy during gastric/esophageal resection: systematic analysis of risks and benefits. World J Surg 34(5):1008–1014
doi: 10.1007/s00268-010-0444-1 pubmed: 20135313
Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y (2005) Analysis of risk factors for the development of gallstones after gastrectomy. Br J Surg 92(11):1399–1403
doi: 10.1002/bjs.5117 pubmed: 16078296
Lai SL, Yang JC, Wu JM, Lai IR, Chen CN, Lin MT et al (2013) Combined cholecystectomy in gastric cancer surgery. Int J Surg 11(4):305–308
doi: 10.1016/j.ijsu.2013.02.006 pubmed: 23434939
Tsunoda K, Shirai Y, Wakai T, Yokoyama N, Akazawa K, Hatakeyama K (2004) Increased risk of cholelithiasis after esophagectomy. J Hepatobiliary Pancreat Surg 11(5):319–323
doi: 10.1007/s00534-004-0914-7 pubmed: 15549430
Yi SQ, Ohta T, Tsuchida A, Terayama H, Naito M, Li J et al (2007) Surgical anatomy of innervation of the gallbladder in humans and Suncus murinus with special reference to morphological understanding of gallstone formation after gastrectomy. World J Gastroenterol 13(14):2066–2071
doi: 10.3748/wjg.v13.i14.2066 pubmed: 17465449 pmcid: 4319126
Liu H, Liu J, Xu W, Chen X (2022) Prophylactic cholecystectomy: a valuable treatment strategy for cholecystolithiasis after gastric cancer surgery. Front Oncol 12:897853
doi: 10.3389/fonc.2022.897853 pubmed: 36176409 pmcid: 9513465
Liang TJ, Liu SI, Chen YC, Chang PM, Huang WC, Chang HT et al (2017) Analysis of gallstone disease after gastric cancer surgery. Gastric Cancer 20(5):895–903
doi: 10.1007/s10120-017-0698-5 pubmed: 28154944
Kimura J, Kunisaki C, Takagawa R, Makino H, Ueda M, Ota M et al (2017) Is routine prophylactic cholecystectomy necessary during gastrectomy for gastric cancer? World J Surg 41(4):1047–1053
doi: 10.1007/s00268-016-3831-4 pubmed: 27896408
Akatsu T, Yoshida M, Kubota T, Shimazu M, Ueda M, Otani Y et al (2005) Gallstone disease after extended (D2) lymph node dissection for gastric cancer. World J Surg 29(2):182–186
doi: 10.1007/s00268-004-7482-5 pubmed: 15654665
Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Clark Gamblin T, Turaga KK (2014) Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis. Ann Surg Oncol 21(1):240–247
doi: 10.1245/s10434-013-3300-3 pubmed: 24114054
Harino T, Tomimaru Y, Yokota Y, Noguchi K, Shimizu J, Taguchi T et al (2020) Surgical outcome of laparoscopic cholecystectomy in patients with a history of gastrectomy. Surg Laparosc Endosc Percutan Tech 31(2):170–174
doi: 10.1097/SLE.0000000000000855 pubmed: 32890252
Tan Z, Xie P, Qian H, Yao X (2019) Clinical analysis of prophylactic cholecystectomy during gastrectomy for gastric cancer patients: a retrospective study of 1753 patients. BMC Surg 19(1):48
doi: 10.1186/s12893-019-0512-x pubmed: 31088424 pmcid: 6515595
Bencini L, Marchet A, Alfieri S, Rosa F, Verlato G, Marrelli D et al (2019) The Cholegas trial: long-term results of prophylactic cholecystectomy during gastrectomy for cancer-a randomized-controlled trial. Gastric Cancer 22(3):632–639
doi: 10.1007/s10120-018-0879-x pubmed: 30244294
Tachibana M, Kinugasa S, Yoshimura H, Dhar DK, Ueda S, Fujii T et al (2003) Acute cholecystitis and cholelithiasis developed after esophagectomy. Can J Gastroenterol 17(3):175–178
doi: 10.1155/2003/987946 pubmed: 12677266
Gehwolf P, Renz O, Brenner E, Cardini B, Lorenz A, Wykypiel H (2020) Laparoscopic fundoplication and new aspects of neural anatomy at the oesophagogastric junction. BJS Open 4(3):400–404
doi: 10.1002/bjs5.50271 pubmed: 32134571 pmcid: 7260418
Sneineh MA, Harel L, Elnasasra A, Razin H, Rotmensh A, Moscovici S et al (2020) Increased incidence of symptomatic cholelithiasis after bariatric Roux-en-Y gastric bypass and previous bariatric surgery: a single center experience. Obes Surg 30(3):846–850
doi: 10.1007/s11695-019-04366-6 pubmed: 31901127
Talha A, Abdelbaki T, Farouk A, Hasouna E, Azzam E, Shehata G (2020) Cholelithiasis after bariatric surgery, incidence, and prophylaxis: randomized controlled trial. Surg Endosc 34(12):5331–5337
doi: 10.1007/s00464-019-07323-7 pubmed: 31858245
Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P (2009) Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc 23(7):1640–1644
doi: 10.1007/s00464-008-0204-6 pubmed: 19057954
Zhang MJ, Yan Q, Zhang GL, Zhou SY, Yuan WB, Shen HP (2016) Laparoscopic cholecystectomy in patients with history of gastrectomy. JSLS 20(4):e2016.00075
Choi JH, Lee SH, Cho IR, Paik WH, Ryu JK, Kim YT (2021) Ursodeoxycholic acid for the prevention of gallstone and subsequent cholecystectomy following gastric surgery: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci 28(5):409–418
doi: 10.1002/jhbp.946 pubmed: 33768730
Miftode SV, Troja A, El-Sourani N, Raab HR, Antolovic D (2014) Simultaneous cholecystectomy during gastric and oesophageal resection: a retrospective analysis and critical review of literature. Int J Surg 12(12):1357–1359
doi: 10.1016/j.ijsu.2014.10.039 pubmed: 25448658
Gutt C, Jenssen C, Barreiros AP, Götze TO, Stokes CS, Jansen PL et al (2018) Updated S3-guideline for prophylaxis, diagnosis and treatment of gallstones. German Society for Digestive and Metabolic Diseases (DGVS) and German Society for Surgery of the Alimentary Tract (DGAV) - AWMF Registry 021/008. Z Gastroenterol 56(8):912–966

Auteurs

Katharina Esswein (K)

Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Philipp Gehwolf (P)

Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Heinz Wykypiel (H)

Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Reinhold Kafka-Ritsch (R)

Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria. reinhold.kafka-ritsch@tirol-kliniken.at.

Classifications MeSH